EP
CFMS

Eudaimonia Partners’s Conformis, Inc. Common Stock CFMS Stock Holding History

Eudaimonia Partners’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-741
Closed -$18K – 1484
2021
Q1 		$18K Buy
+741
New +$20K ﹤0.01% 985

Other funds holding CFMS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Eudaimonia Partners's CFMS Position: Q2 2021 in Review

Eudaimonia Partners sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2021, closing a stake of 741 shares — an estimated $18K sold.

Eudaimonia Partners first reported a position in CFMS in Q1 2021 and held it in 1 quarter. The position peaked at $18K in Q1 2021. 78 funds tracked by Wall St. Rank hold CFMS as of Q2 2021.

  • Eudaimonia Partners reported no remaining Conformis, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 741 Conformis, Inc. Common Stock shares in Q2 2021, an estimated $18K.
  • Eudaimonia Partners first reported a position in Conformis, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Conformis, Inc. Common Stock position peaked at $18K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.